Table 1.
Group | N | Tumor model | PET tracer | SA (GBq/µmol) |
---|---|---|---|---|
Subcutaneous xenograft | ||||
1 | 4 | HepG2(R)/Huh7(L) | 89Zr-Df-YY146 | 44.4 |
2 | 3 | HepG2(R)/Huh7(L) | 89Zr-Df-YY146 + YY146 (50 mg/kg) | 44.4 |
3 | 5 | HepG2 | 89Zr-Df-YY146-ZW800 | 18.5 |
4 | 3 | HepG2 | 89Zr-Df-YY146-ZW800 | 29.6 |
5 | 4 | HepG2 | 89Zr-Df-YY146-ZW800 + YY146 (50 mg/kg) | 29.6 |
6 | 3 | Huh7 | 89Zr-Df-YY146-ZW800 | 29.6 |
Orthotopic xenografts | ||||
7 | 4 | HepG2 | 89Zr-Df-YY146-ZW800 | 29.6 |
8 | 5 | HepG2 | 89Zr-Df-YY146-ZW800 | 18.5 |
R: right flank; L: left flank; SA: specific activity |